Capital International Investors

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1562230 Los Angeles, CA

Position in NAMS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$58,409,245

+$12,278,642 QoQ

Shares Held

1,723,495

+19.6% QoQ

Ownership

1.44%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#16

of 198 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. NAMS ranks #15 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,695,144	$2,332,218,879
2	RPRX	Royalty Pharma plc	35,273,770	$1,977,800,283
3	ONC	BeOne Medicines Ltd.	4,210,221	$1,199,786,678
4	INSM	INSMED Inc	8,238,124	$878,348,780
5	ASND	Ascendis Pharma A/S	1,988,614	$530,403,126
6	XENE	Xenon Pharmaceuticals Inc.	2,361,639	$142,548,530
7	DFTX	Definium Therapeutics, Inc.	2,963,410	$139,398,806
8	COAG	Hemab Therapeutics Holdings, Inc.	3,603,876	$132,370,365

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$58,409,245	1,723,495	+19.6%	Shares	Defined	2026-08-12
2026-03-31	$46,130,603	1,441,131	-30.1%	Shares	Defined	2026-05-13
2025-12-31	$72,353,727	2,062,535	0.0%	Shares	Defined	2026-02-11
2025-09-30	$58,658,495	2,062,535	0.0%	Shares	Defined	2025-11-13
2025-06-30	$37,352,508	2,062,535	0.0%	Shares	Defined	2025-08-13
2025-03-31	$42,220,091	2,062,535	0.0%	Shares	Defined	2025-05-12
2024-12-31	$53,007,149	2,062,535	—	Shares	Defined	2025-02-13
No filing history on record for this holder in this stock.